These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 11781363)

  • 21. Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.
    Nattermann J; Nischalke HD; Feldmann G; Ahlenstiel G; Sauerbruch T; Spengler U
    J Viral Hepat; 2004 Nov; 11(6):519-26. PubMed ID: 15500552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus-infected cells downregulate NKp30 and inhibit ex vivo NK cell functions.
    Holder KA; Stapleton SN; Gallant ME; Russell RS; Grant MD
    J Immunol; 2013 Sep; 191(6):3308-18. PubMed ID: 23960237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity.
    Oliviero B; Mantovani S; Varchetta S; Mele D; Grossi G; Ludovisi S; Nuti E; Rossello A; Mondelli MU
    J Hepatol; 2017 Jun; 66(6):1130-1137. PubMed ID: 28192188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small molecule inhibition of hepatitis C virus E2 binding to CD81.
    VanCompernolle SE; Wiznycia AV; Rush JR; Dhanasekaran M; Baures PW; Todd SC
    Virology; 2003 Sep; 314(1):371-80. PubMed ID: 14517089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine-activated natural killer cells exert direct killing of hepatoma cells harboring hepatitis C virus replicons.
    Larkin J; Bost A; Glass JI; Tan SL
    J Interferon Cytokine Res; 2006 Dec; 26(12):854-65. PubMed ID: 17238828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD81 engineered with endocytotic signals mediates HCV cell entry: implications for receptor usage by HCV in vivo.
    Tan YJ; Lim SP; Ng P; Goh PY; Lim SG; Tan YH; Hong W
    Virology; 2003 Apr; 308(2):250-69. PubMed ID: 12706076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines.
    Hamaia S; Li C; Allain JP
    Blood; 2001 Oct; 98(8):2293-300. PubMed ID: 11588022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C.
    Nattermann J; Zimmermann H; Iwan A; von Lilienfeld-Toal M; Leifeld L; Nischalke HD; Langhans B; Sauerbruch T; Spengler U
    Hepatology; 2006 Oct; 44(4):945-54. PubMed ID: 17006905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-linking of CD81 by HCV-E2 protein inhibits human intrahepatic plasmacytoid dendritic cells response to CpG-ODN.
    Tu Z; Zhang P; Li H; Niu J; Jin X; Su L
    Cell Immunol; 2013; 284(1-2):98-103. PubMed ID: 23954883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders.
    Rosa D; Saletti G; De Gregorio E; Zorat F; Comar C; D'Oro U; Nuti S; Houghton M; Barnaba V; Pozzato G; Abrignani S
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18544-9. PubMed ID: 16339892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-stimulation of CD81 expression by resting B cells increases proliferation following EBV infection, but the overexpression of CD81 induces the apoptosis of EBV-transformed B cells.
    Park GB; Kim D; Park SJ; Lee HK; Kim JH; Kim YS; Park SG; Choi IH; Yoon SH; Lee YJ; Paeng S; Hur DY
    Int J Mol Med; 2015 Dec; 36(6):1464-78. PubMed ID: 26498453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.
    Oliviero B; Varchetta S; Paudice E; Michelone G; Zaramella M; Mavilio D; De Filippi F; Bruno S; Mondelli MU
    Gastroenterology; 2009 Sep; 137(3):1151-60, 1160.e1-7. PubMed ID: 19470388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection.
    Zhao X; Tang ZY; Klumpp B; Wolff-Vorbeck G; Barth H; Levy S; von Weizsäcker F; Blum HE; Baumert TF
    J Clin Invest; 2002 Jan; 109(2):221-32. PubMed ID: 11805134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells.
    Mazzocca A; Sciammetta SC; Carloni V; Cosmi L; Annunziato F; Harada T; Abrignani S; Pinzani M
    J Biol Chem; 2005 Mar; 280(12):11329-39. PubMed ID: 15611113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1.
    Goh CC; Roggerson KM; Lee HC; Golden-Mason L; Rosen HR; Hahn YS
    J Immunol; 2016 Mar; 196(5):2283-92. PubMed ID: 26826241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations within the CD81-binding sites and hypervariable region 2 of the envelope 2 protein: correlation with treatment response in hepatitis C virus-infected patients.
    Hofmann WP; Sarrazin C; Kronenberger B; Schönberger B; Bruch K; Zeuzem S
    J Infect Dis; 2003 Mar; 187(6):982-7. PubMed ID: 12660945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines.
    D'Agosto G; Trento E; Nosotti L; Bordignon V; Battista M; Prignano G; Pimpinelli F; Biolcati G; Macrì A; Palamara G; Miglioresi L; Morrone A; Di Carlo A; Cordiali-Fei P; Ensoli F
    J Biol Regul Homeost Agents; 2009; 23(3):155-64. PubMed ID: 19828092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein.
    Flint M; Dubuisson J; Maidens C; Harrop R; Guile GR; Borrow P; McKeating JA
    J Virol; 2000 Jan; 74(2):702-9. PubMed ID: 10623732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver.
    Curry MP; Golden-Mason L; Doherty DG; Deignan T; Norris S; Duffy M; Nolan N; Hall W; Hegarty JE; O'Farrelly C
    J Hepatol; 2003 May; 38(5):642-50. PubMed ID: 12713876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection.
    Zuckerman E; Slobodin G; Kessel A; Sabo E; Yeshurun D; Halas K; Toubi E
    Clin Exp Immunol; 2002 May; 128(2):353-8. PubMed ID: 11985527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.